Updated Data Matrix Available

Market Value | Market Volume | Epidemiology | Clinical Trials | Patent Landscape | Regulatory Approvals | COVID-19 Impact Analysis

Global Cardiopulmonary Stress Testing Market $9.2 Billion by 2027

The global market for cardiopulmonary stress testing devices anticipated to attain $9.2 billion by 2027, growing at a CAGR of 8.9% over the forecast period, driven by increasing prevalence of coronary artery diseases and pulmonary diseases worldwide.

  • Other factors supplementing the market growth include rapidly aging population couple with rising obesity rate, introduction of improved monitoring products and technologies as well as eradication of complications associated with stress testing due to the development of robust and flexible devices.
Global Cardiopulmonary Stress Testing Market

Cardiopulmonary exercise testing (CPET) has become an important clinical tool to evaluate exercise capacity and predict outcome in patients with heart failure and other cardiac conditions.

  • CPET provides assessment of the integrative exercise responses involving the pulmonary, cardiovascular and skeletal muscle systems, which are not adequately reflected through the measurement of individual organ system function. 
    • CPET involves measurements of respiratory oxygen uptake (Vo2), carbon dioxide production (Vco2), and ventilatory measures during a symptom‐limited exercise test. 
      • Cardiopulmonary exercise testing is a blend of conventional exercise testing procedures (e.g. ECG, blood pressure) along with ventilatory expired gas analysis (e.g. oxygen consumption, carbon dioxide production and minute ventilation). 

Commonly used cardiopulmonary stress testing products:

  • The devices used for patient exercise include stationary bicycle ergometers and treadmills.
    • Electrocardiograph recording throughout exercise testing evaluates heart rate, heart rhythm, and screens for ischemic changes precipitated by exercise.
    • Blood pressure monitoring evaluates for blood pressure response to exercise and may also identify decline in blood pressure in patients at risk of exertional syncope.
      • Manual blood pressure monitoring is generally recommended for accurate measurement.
    • Pulse oximetry used as a non-invasive assessment of arterial blood saturation.
      • Evaluation of ventilation, gas exchange, and metabolic rate and function is accomplished through airflow measurement, capnometry, oximetry, and quantification of expired gases. 
        • In selected circumstances, arterial blood gas analysis can also be obtained for further analysis of gas exchange, acid-base status and blood lactate levels.
Cardiopulmonary Stress Testing Devices Market

The global cardiopulmonary stress testing devices market report provides market size estimates ($million 2017 to 2027), market share, growth trends and forecast (CAGR% 2021 to 2027).

The global market for cardiopulmonary stress testing (CPST) systems segmented by product [cardiopulmonary exercise testing (CPET/CPEx) monitors (desktop CPET monitors, portable CPET monitors), pulse oximeter monitors, single-photon emission computed tomography (SPECT or SPET), stress blood pressure monitors, stress electrocardiography (ECG) monitors], end user [ambulatory surgical centers, hospitals, specialty clinics (cardiology)], and geography.

  • Based on products, the cardiopulmonary exercise testing (CPET) systems segment accounted for the majority of market share and is anticipated to grow at the fastest rate during the forecast period.
    • CPET is a non-invasive and sensitive stress testing clinical tool most widely used for the assessment of pulmonary, cardiovascular, neuropsychological, hematopoietic, and skeletal muscle systems’ response to exercise.
      • The CPET test has been beneficial in the detection of heart and lung disorders such as ischemic heart disease, heart failure, shortness of breath, asthma, and other pulmonary disorders.
        • Some CPET systems available in the market include CASE ES Ergospirometry Testing System, and StressVue Stress Testing System, etc.
  • Although stationary systems sub-segment dominated CPET systems market, the portable version sub-segment expected to witness higher CAGR in the near future.
    • Technological advancements in portable CPET systems such as expanded networking operations, seamless connectivity with different medical imaging systems such as picture archiving and communication system (PACS), MUSE, and others have enabled the acceptance and adoption of these systems by healthcare professionals.

The global market for cardiopulmonary stress testing products research report is further divided by geography into North America (U.S., Canada), Europe (U.K., Germany, France, Italy, Spain, Rest of EU), Asia Pacific (Japan, China, India, Rest of APAC), Latin America (Brazil, Mexico, Rest of LA) and Rest of the World.

  • In terms of geography, the North America region held the largest share of the global CPST systems market, followed by the Europe region, attributed to increasing pool of cardiopulmonary patients and presence of large number of healthcare facilities adopting innovative products in the developed economies.
    • However, the Asia Pacific CPST systems market forecast to expand at a double-digit growth rate over the next few years, owing to increasing disposable income, large population base, and rising number of patients diagnosed with cardiovascular diseases in the developing nations.

The global market research report also provides the detailed market landscape, market drivers, restraints, opportunities), market attractiveness analysis and profiles of major competitors in the global market including company overview, financial snapshot, key products, technologies and services offered, and recent developments.

Major competitors operating in the global market for cardiopulmonary exercise testing devices and included in this report are Altus Capital Partners, Inc. (MGC Diagnostics Corp. / Medisoft), Becton, Dickinson and Company (CareFusion Corp.), COSMED Srl, GE Healthcare, Hill-Rom Holdings, Inc. (Welch Allyn, Inc.), Nihon Kohden Corporation, Philips Healthcare, Schiller AG, Spacelabs Healthcare (OSI Systems), SunTech Medical, Inc. and Vyaire Medical, Inc.

  • Product
    • Cardiopulmonary Exercise Testing (CPET/CPEx) Monitors
      • Desktop CPET Monitors
      • Portable CPET Monitors
    • Pulse Oximeter Monitors
    • Single-photon emission computed tomography (SPECT or SPET)
    • Stress Blood Pressure Monitors
    • Stress Electrocardiography (ECG) Monitors
  • End User
    • Ambulatory Surgical Centers (ASCs)
    • Hospitals
    • Specialty Clinics (Cardiology)
    • Others
  • Geography
    • North America (U.S., Canada)
    • Europe (U.K., Germany, France, Italy, Spain, Rest of EU)
    • Asia Pacific (Japan, China, India, Rest of APAC)
    • Latin America (Brazil, Mexico, Rest of LA)
    • Rest of the World
  • Company Profiles
    • Altus Capital Partners, Inc. (MGC Diagnostics Corp. / Medisoft)
    • Becton, Dickinson and Company (CareFusion Corp.)
    • COSMED Srl
    • GE Healthcare
    • Hill-Rom Holdings, Inc. (Welch Allyn, Inc.)
    • Nihon Kohden Corporation
    • Philips Healthcare
    • Schiller AG
    • Spacelabs Healthcare (OSI Systems)
    • SunTech Medical, Inc.
    • Vyaire Medical, Inc.

To request Table of Contents and Sample Pages of this report visit:

Related publications:

    Request ToC/Sample information for this market analysis

    Full Name*

    Company Email*

    Phone Number* [Please add country code]



    Secure Online Payment

    iHealthcareAnalyst, Inc.

    Contact Address

    US Office: 2109, Mckelvey Hill Drive, Maryland Heights, MO 63043, United States
    Phone: +1 (314) 315-4764
    India Office: 5, Shilpa Chambers, Opp. J. M. Road, Shivajinager, Pune 411005, India
    Phone: +91 (20) 25898524
    Email: [email protected]